CaV2.1 mediates presynaptic dysfunction induced by amyloid β oligomers.
Ontology highlight
ABSTRACT: Synaptic dysfunction is an early pathological phenotype of Alzheimer's disease (AD) that is initiated by oligomers of amyloid β peptide (Aβos). Treatments aimed at correcting synaptic dysfunction could be beneficial in preventing disease progression, but mechanisms underlying Aβo-induced synaptic defects remain incompletely understood. Here, we uncover an epithelial sodium channel (ENaC) - CaV2.3 - protein kinase C (PKC) - glycogen synthase kinase-3β (GSK-3β) signal transduction pathway that is engaged by Aβos to enhance presynaptic CaV2.1 voltage-gated Ca2+ channel activity, resulting in pathological potentiation of action-potential-evoked synaptic vesicle exocytosis. We present evidence that the pathway is active in human
SUBMITTER: Jeans AF
PROVIDER: S-EPMC12799594 | biostudies-literature | 2025 Apr
REPOSITORIES: biostudies-literature
ACCESS DATA